Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2747-04-8

Post Buying Request

2747-04-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2747-04-8 Usage

Chemical Properties

7-ACETOXY-4-BROMOMETHYLCOUMARIN is Off-White Crystalline Solid

Uses

7-ACETOXY-4-BROMOMETHYLCOUMARIN is a fluorescent reagent used for labelling carboxylic acids

Check Digit Verification of cas no

The CAS Registry Mumber 2747-04-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,7,4 and 7 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2747-04:
(6*2)+(5*7)+(4*4)+(3*7)+(2*0)+(1*4)=88
88 % 10 = 8
So 2747-04-8 is a valid CAS Registry Number.
InChI:InChI=1/C12H9BrO4/c1-7(14)16-9-2-3-10-8(6-13)4-12(15)17-11(10)5-9/h2-5H,6H2,1H3

2747-04-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name [4-(bromomethyl)-2-oxochromen-7-yl] acetate

1.2 Other means of identification

Product number -
Other names 7-ACETOXY-4-BROMOMETHYLCOUMARIN

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2747-04-8 SDS

2747-04-8Relevant articles and documents

Psoralens for pathogen inactivation

-

, (2008/06/13)

Psoralen compound compositions are synthesized which have primaryamino substitutions on the 3-, 4-, 5-, and 8- positions of the psoralen, which yet permit their binding to nucleic acid of pathogens. Reaction conditions that photoactivate these psoralens result in the inactivation of pathogens which contain nucleic acid. The compounds show similar activity in test systems to 4'' and 5'' derivatives of psoralen useful for inactivation of pathogens in blood products. In addition to the psoralen compositions, the invention contemplates such inactivating methods using the new psoralens.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2747-04-8